CL
Colgate-Palmolive Co.
NYSE · Consumer Defensive · Household & Personal Products · US
$94.11
+1.55%Year over year
Reported trailing growth
- Revenue
- +5.2%
- EBITDA
- -19.8%
- EBIT
- -0.2%
- EPS
- -28.9%
- Free cash flow
- +14.5%
- Operating cash flow
- +13.7%
Forward estimates
Based on analyst estimates
- Revenue
- +4.0%
- EBITDA
- +43.8%
- EPS
- +57.3%
Three-year CAGR
- Revenue
- +4.3%
- EBITDA
- +13.0%
- EBIT
- -2.7%
- Net income
- +6.1%
- EPS
- +7.4%
- Free cash flow
- +25.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026